FDA Authorized COVID “Vaccines” For Children As Young As 6 Months

The FDA has decided to authorize the COVID-19 Omicron booster shot “vaccines” for the youngest kids as the mainstream media continues to panic the public over Covid infections and hospitalizations that are allegedly increasing nationally. Children as young as six months can now be injected with the substance.

CDC data: Fully vaccinated kids are more likely to get COVID-19 than unvaccinated kids

The eligibility rules vary depending on whether children have already received Moderna or Pfizer’s original vaccines as their primary series.

According to a  report by CNBC, the following are the new eligibility criteria:

  • Children 6 months through 5 years old who received Moderna’s two-dose primary series are now eligible for an omicron booster two months after their second shot.
  • Kids ages 6 months through 4 years old who have not yet received the third dose of Pfizer’s primary series will now receive the omicron shot as their third dose.

The Centers for Disease Control and Prevention needs to sign off on the shots before pharmacies and physicians can start administering them to children. Dr. Peter Marks, head of the FDA’s vaccine division, told parents in a statement that the agency carefully reviewed the shots before authorizing them. Dr. Robert Califf, head of the FDA, said it’s important for people to stay up to date on their shots this winter because immunity against the virus wanes.

But does immunity wane? Or is something else going on?

U.S. Ruling Class Data: Fully “Vaccinated” Are Developing AIDS

The new shots target the quickly diminishing omicron BA.5 subvariant and the original COVID strain. U.S. health officials keep using propaganda to say that the new shots provide superior protection compared to the original vaccines, which only target the original COVID strain. But the available efficacy and immune response data for adults have been mixed.

It sure seems like the ruling class still hasn’t gotten these gene therapy drugs in enough of the population just yet. CNBC even admits that these shots are not going to work aginst the new omicron variants going around. So what’s the point?

The new shots likely won’t perform as well against the BQ subvariants compared with BA.5 because they are more immune evasive, though they are still expected to provide good protection against severe illness. –CNBC

We can likely expect more illness, “died suddenly” headlines and myocarditis in the future of those naive enough to continue to be injected upon command.

- Advertisement -

Links to check out

Latest Articles